Technological developments in reproductive medicine, driven by the convergence of micro-robotics and nanosensors, along with decision-making aided by artificial intelligence, are enabling precise manipulation, gamete selection, embryo assessment and personalized treatment. These disruptive advances could lead to fully automated in vitro fertilization workflows. However, clinical implementation will need to address various technical, biological and ethical challenges to ensure safer and more effective fertility solutions.
- Friedrich Striggow
- Pallavi Jha
- Mariana Medina-Sánchez
